IRCT20211212053372N1尚未招募3 期
Comparison of the effect of cabergoline, letrozole and triptorelin on the treatment of uterine myomas: a randomized clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 45 years（—）
- 性别
- Female
入选标准
- •20-45 years old women with uterine myoma (size 3 to 8 cm) presenting bleeding and pelvic pain.
排除标准
- •Patients who have a hemoglobin level of 9 grams per deciliter or higher and consume iron pills.
- •Patients over the age of 45 years.
- •Patients with basal myoma who have received hormonal treatment in the past three months.
- •Patients with kidney and/or liver disease.
- •Consumers of antipsychotic drugs.
- •Patients with a history of drug treatment or surgery for uterine myoma with severe bleeding
研究者
相似试验
尚未招募
4 期
To compare the effectiveness of cabergoline and medroxyprogesterone acetate in the treatment of uterine adenomyosisCTRI/2020/04/024422SRM College of Pharmacy
招募中
3 期
Comparative study between cabergoline and intravenous calcium in the prevention of ovarian hyper stimulation in women with polycystic ovarian disease undergoing Intracytoplasmic sperm injection (ICSI ).subfertilityovarian hyperstimulationPoly cystic ovarian diseaseReproductive Health and Childbirth - Fertility including in vitro fertilisationACTRN12613000904774Eman Elkattan100
招募中
3 期
Comparison of the effect of two methods of cabergoline administration to prevent ovarian hyperstimulation syndrome in women with polycystic ovary syndromeIRCT20090526001952N16Tehran University of Medical Sciences200
已完成
3 期
A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLSRestless Legs SyndromeNCT00625547Pfizer361
尚未招募
Unknown
Comparison of the effect of Cabergoline versus Dienogest on markers in endometriosisCTRI/2023/04/051886il